Steven Cohen Novavax Inc Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Novavax Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 120,000 shares of NVAX stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120,000
Previous 120,000
-0.0%
Holding current value
$1.63 Million
Previous $1.52 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NVAX
# of Institutions
285Shares Held
84.3MCall Options Held
5.43MPut Options Held
9M-
Vanguard Group Inc Valley Forge, PA14.1MShares$192 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$161 Million0.0% of portfolio
-
Shah Capital Management9.66MShares$132 Million41.87% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.32MShares$86 Million0.08% of portfolio
-
State Street Corp Boston, MA6.07MShares$82.6 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $1.06B
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...